Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis

Original Article

M.E. Wechsler, P. Nair, B. Terrier, B. Walz, A. Bourdin, D.R. Jayne, D.J. Jackson, F. Roufosse, L.B. Sjö, Y. Fan, M. Jison, C. McCrae, S. Necander, A. Shavit, C. Walton, and P.A. Merkel

N Engl J Med 2024;390:911-921

Course summary

Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
03/06/2024
Course expires: 
03/07/2026

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.